NurOwn® (autologous MSC-NTF cells) in ALS - phase 3 clinical trial - Chartable

Brain Matters (Video)

NurOwn® (autologous MSC-NTF cells) in ALS - phase 3 clinical trial update - Ralph Kern

Listen now

Description

Ralph Kern MD MHSc Brainstorm Cell Therapeutics Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36320]

More Episodes

Exercise Improves Brain Health?

Published 09/09/24

Risk Factors for Alzheimer's What You Can Change

Published 08/29/24

Diet's Effect On Cognitive Decline Vascular Risk

Published 08/21/24